Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-20

Clinical Trial Update: Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing imiquimod, fluorouracil, or observation in HIV-positive individuals with high-grade anal intraepithelial neoplasia/HSIL; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Imiquimod (imiquimod)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Intraepithelial Neoplasia, High-grade Squamous Intraepithelial Lesion | Phase 3 | Status: COMPLETED | Results posted: 2025-05-20